New Findings • Castleman Disease can progress from a unicentric to a multicentric form in children. • Subcutaneous tocilizumab is a safe and effective ther apy for patients with Castleman Disease, improving quality of life and eliminating the need for frequent hospital admissions for intravenous infusions
Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease Progressing From Unicentric to Multicentric Form / Naviglio, S., Nicolardi, F., Bussani, R., Tommasini, A., Barbi, E., Rabusin, M.. - In: JOURNAL OF PAEDIATRICS AND CHILD HEALTH. - ISSN 1034-4810. - ELETTRONICO. - (2026), pp. 1-4. [10.1111/jpc.70404]
Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease Progressing From Unicentric to Multicentric Form
Nicolardi, Francesca;Bussani, Rossana;Tommasini, Alberto;Barbi, Egidio;
2026-01-01
Abstract
New Findings • Castleman Disease can progress from a unicentric to a multicentric form in children. • Subcutaneous tocilizumab is a safe and effective ther apy for patients with Castleman Disease, improving quality of life and eliminating the need for frequent hospital admissions for intravenous infusionsFile in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
